pharmadog

News

when

Latest
Archive

by source

All Sources
Sources Page

Jobs

department

Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access

therapeutic area

Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease

location & type

Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →

pharmadog

fetch the data · sniff the signal

Discover

Jobs
News

Hubs

Topics
Patent cliff
Publications

Tools

Compare
Search
Bookmarks

Trust

About
Sources
Contact

Legal

Privacy
Terms
Pricing

made by humans and a good dog

home
jobs
news
search

calendar

45 catalysts · 22 drug shortage · 13 approval · 9 grant · 1 recall

★ save view ↓export CSV

next 91 dayslessmore

MonWedFri

view

agenda month

sort

soonest latest type sponsor alpha

from 2026-04-17×to 2026-04-17×clear all

type

drug shortage22
approval13
grant9
recall1

therapy area

no tagged catalysts yet

Week of Apr 13, 2026

›

04/17/2026

recall

116d ago

Breeder’s Edge, Shelter’s Choice recall: Animal & Veterinary, Food & Beverages

Canine milk replacer

full page →fda recalls ↗

›Apr 17, 2026approval116d agoSODIUM ACETATE — FDA approvalSODIUM ACETATE

Sponsor: EXTROVIS. Form: SOLUTION. Route: INTRAVENOUS

full page →SODIUM ACETATE →fda approvals ↗

›Apr 17, 2026approval116d agoCOSENTYX (SECUKINUMAB) — FDA approvalNOVARTIS AG

Sponsor: NOVARTIS PHARMS CORP. Form: INJECTABLE. Route: INJECTION

full page →fda approvals ↗

›Apr 17, 2026approval116d agoCOSENTYX (SECUKINUMAB) — FDA approvalNOVARTIS AG

Sponsor: NOVARTIS PHARMS CORP. Form: INJECTABLE. Route: INJECTION

full page →fda approvals ↗

›Apr 17, 2026approval116d agoCOSENTYX (SECUKINUMAB) — FDA approvalNOVARTIS AG

Sponsor: NOVARTIS PHARMS CORP. Form: INJECTABLE. Route: INJECTION

full page →fda approvals ↗

›Apr 17, 2026approval116d agoCOSENTYX (SECUKINUMAB) — FDA approvalNOVARTIS AG

Sponsor: NOVARTIS PHARMS CORP. Form: INJECTABLE. Route: INJECTION

full page →fda approvals ↗

›Apr 17, 2026approval116d agoVALPROIC ACID — FDA approvalVALPROIC ACID

Sponsor: QUAGEN. Form: SYRUP. Route: ORAL

full page →VALPROIC ACID →fda approvals ↗

›Apr 17, 2026approval116d agoCARBAMAZEPINE — FDA approvalcarbamazepine ER

Sponsor: YICHANG HUMANWELL. Form: TABLET, EXTENDED RELEASE. Route: ORAL

full page →carbamazepine ER →fda approvals ↗

›Apr 17, 2026approval116d agoCALCIPOTRIENE — FDA approvalPrasco LLC

Sponsor: GLENMARK SPECLT. Form: CREAM. Route: TOPICAL

full page →fda approvals ↗

›Apr 17, 2026approval116d agoESOMEPRAZOLE MAGNESIUM — FDA approvalesomeprazole magnesium DR

Sponsor: MARKSANS PHARMA. Form: CAPSULE, DELAYED RELEASE. Route: ORAL

full page →esomeprazole magnesium DR →fda approvals ↗

›Apr 17, 2026approval116d agoLAMOTRIGINE — FDA approvalLAMOTRIGINE

Sponsor: GLENMARK PHARMS LTD. Form: TABLET, FOR SUSPENSION. Route: ORAL

full page →LAMOTRIGINE →fda approvals ↗

›Apr 17, 2026approval116d agoLAMOTRIGINE — FDA approvalLAMOTRIGINE

Sponsor: GLENMARK PHARMS LTD. Form: TABLET, FOR SUSPENSION. Route: ORAL

full page →LAMOTRIGINE →fda approvals ↗

›Apr 17, 2026approval116d agoTETRACYCLINE HYDROCHLORIDE — FDA approvalAmneal Pharmaceuticals of New York LLC

Sponsor: IMPAX LABS. Form: CAPSULE. Route: ORAL

full page →fda approvals ↗

›Apr 17, 2026approval116d agoTETRACYCLINE HYDROCHLORIDE — FDA approvalAmneal Pharmaceuticals of New York LLC

Sponsor: IMPAX LABS. Form: CAPSULE. Route: ORAL

full page →fda approvals ↗

›Apr 17, 2026drug shortage116d agoLisdexamfetamine Dimesylate Capsule shortage — AlvogenAlvogen Inc

Status: Current. Reason: not specified. Form: Capsule

full page →fda drug shortages ↗

›Apr 17, 2026drug shortage116d agoLisdexamfetamine Dimesylate Capsule shortage — Mylan Pharmaceuticals Inc., a Viatris CompanyMylan Pharmaceuticals Inc

Status: Current. Reason: not specified. Form: Capsule

full page →fda drug shortages ↗

›Apr 17, 2026drug shortage116d agoAmphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet shortage — AlvogenAlvogen Inc

Status: Current. Reason: not specified. Form: Tablet

full page →fda drug shortages ↗

›Apr 17, 2026drug shortage116d agoDextrose Monohydrate 5% Injection shortage — Otsuka ICU Medical LLC

Status: Current. Reason: not specified. Form: Injection

full page →fda drug shortages ↗

›Apr 17, 2026drug shortage116d agoLisdexamfetamine Dimesylate Tablet, Chewable shortage — Sun Pharmaceutical Industries, Inc.Sun Pharmaceutical Industries Ltd

Status: Current. Reason: not specified. Form: Tablet, Chewable

full page →fda drug shortages ↗

›Apr 17, 2026drug shortage116d agoMethylphenidate Hydrochloride Tablet, Extended Release shortage — Trigen Laboratories, LLCTrigen Laboratories Inc

Status: Current. Reason: not specified. Form: Tablet

full page →fda drug shortages ↗

›Apr 17, 2026drug shortage116d agoAmino Acid Injection shortage — Otsuka ICU Medical LLC

Status: Current. Reason: not specified. Form: Injection

full page →fda drug shortages ↗

›Apr 17, 2026drug shortage116d agoSterile Water Irrigant shortage — Otsuka ICU Medical LLC

Status: Current. Reason: not specified. Form: Irrigant

full page →fda drug shortages ↗

›Apr 17, 2026drug shortage116d agoEtomidate Injection shortage — Mylan Institutional, a Viatris CompanyMylan Institutional Inc

Status: Current. Reason: not specified. Form: Injection

full page →fda drug shortages ↗

›Apr 17, 2026drug shortage116d agoDextrose Monohydrate 10% Injection shortage — Otsuka ICU Medical LLC

Status: Current. Reason: not specified. Form: Injection

full page →fda drug shortages ↗

›Apr 17, 2026drug shortage116d agoLisdexamfetamine Dimesylate Capsule shortage — Sun Pharmaceutical Industries, Inc.Sun Pharmaceutical Industries Ltd

Status: Current. Reason: not specified. Form: Capsule

full page →fda drug shortages ↗

›Apr 17, 2026drug shortage116d agoTechnetium TC-99M Pyrophosphate Kit Injection shortage — Sun Pharmaceutical Industries, Inc.Sun Pharmaceutical Industries Ltd

Status: Current. Reason: not specified. Form: Injection

full page →fda drug shortages ↗

›Apr 17, 2026drug shortage116d agoPenicillin G Benzathine Injection shortage — Pfizer Inc.PFIZER INC

Status: Current. Reason: not specified. Form: Injection

full page →fda drug shortages ↗

›Apr 17, 2026drug shortage116d agoMethylphenidate Hydrochloride Tablet, Extended Release shortage — Janssen PharmaceuticalsJanssen Therapeutics

Status: Current. Reason: not specified. Form: Tablet

full page →fda drug shortages ↗

›Apr 17, 2026drug shortage116d agoMethylphenidate Hydrochloride Tablet, Extended Release shortage — Sun Pharmaceutical Industries, Inc.Sun Pharmaceutical Industries Ltd

Status: Current. Reason: not specified. Form: Tablet

full page →fda drug shortages ↗

›Apr 17, 2026drug shortage116d agoDexamethasone Sodium Phosphate Injection shortage — Mylan Institutional, a Viatris CompanyMylan Institutional Inc

Status: Current. Reason: not specified. Form: Injection

full page →fda drug shortages ↗

›Apr 17, 2026drug shortage116d agoDexmedetomidine Hydrochloride Injection shortage — Mylan Institutional, a Viatris CompanyMylan Institutional Inc

Status: Current. Reason: not specified. Form: Injection

full page →fda drug shortages ↗

›Apr 17, 2026drug shortage116d agoRemifentanil Hydrochloride Injection shortage — Mylan Institutional, a Viatris CompanyMylan Institutional Inc

Status: Current. Reason: not specified. Form: Injection

full page →fda drug shortages ↗

›Apr 17, 2026drug shortage116d agoDextrose Monohydrate 70% Injection shortage — Otsuka ICU Medical LLC

Status: Current. Reason: not specified. Form: Injection

full page →fda drug shortages ↗

›Apr 17, 2026drug shortage116d agoRocuronium Bromide Injection shortage — Mylan Institutional, a Viatris CompanyMylan Institutional Inc

Status: Current. Reason: not specified. Form: Injection

full page →fda drug shortages ↗

›Apr 17, 2026drug shortage116d agoCromolyn Sodium Concentrate shortage — Mylan Specialty, a Viatris CompanyVitalgenics LLC

Status: Current. Reason: not specified. Form: Concentrate

full page →fda drug shortages ↗

›Apr 17, 2026drug shortage116d agoRifampin Injection shortage — Mylan Institutional, a Viatris CompanyMylan Institutional Inc

Status: Current. Reason: not specified. Form: Injection

full page →fda drug shortages ↗

›Apr 17, 2026grant116d agoUNIVERSITY OF WASHINGTON — Mentoring patient-oriented research on point-of-care diagnostics for infectio...University of Washington

AI grant. $209,758. PI: Paul K Drain

full page →nih reporter ↗

›Apr 17, 2026grant116d agoUNIVERSITY OF CALIFORNIA, SAN FRANCISCO — Assessing multi-site feasibility of an integrated whole-body hyperthermia and...University of California San Francisco

AT grant. $601,259. PI: Ashley E. Mason

full page →nih reporter ↗

›Apr 17, 2026grant116d agoUNIVERSITY OF SOUTH FLORIDA — Aligning Circuit-Directed Rehabilitation with HPA Axis for Improved TBI Recovery

NS grant. $568,920. PI: Theresa Currier Thomas

full page →nih reporter ↗

›Apr 17, 2026grant116d agoNORTHWESTERN UNIVERSITY AT CHICAGO — Disrupting the Peri-necrotic Engine of Immunosuppression in GlioblastomaNorthwestern University

CA grant. $496,357. PI: DANIEL J BRAT

full page →nih reporter ↗

›Apr 17, 2026grant116d agoMASSACHUSETTS GENERAL HOSPITAL — Toolkit for Optimal Pain Management in the Emergency Department: A mind-body ...Massachusetts General Hospital

AT grant. $170,640. PI: Julia E. Hooker

full page →nih reporter ↗

›Apr 17, 2026grant116d agoRUTGERS BIOMEDICAL AND HEALTH SCIENCES — Novel Pediatric TB Diagnostics using Host and Microbial Biomarkers

AI grant. $210,302. PI: William Evan Johnson

full page →nih reporter ↗

›Apr 17, 2026grant116d agoUNIVERSITY OF MICHIGAN AT ANN ARBOR — Remote Loading of Melanocortin and GLP-1 Peptides in Polymers for Treatment o...

DK grant. $231,000. PI: Roger D. Cone

full page →nih reporter ↗

›Apr 17, 2026grant116d agoRESEARCH TRIANGLE INSTITUTE — Development of Neuromedin Receptor 2 antagonists as Novel Analgesics

NS grant. $230,562. PI: Thuy Nguyen

full page →nih reporter ↗

›Apr 17, 2026grant116d agoUNIVERSITY OF CALIFORNIA, SAN FRANCISCO — Analyzing the Distribution, Effectiveness, and Implementation of Wildfire Smo...University of California San Francisco

ES grant. $117,747. PI: Rebecca Sugrue

full page →nih reporter ↗

$PFE27.05+1.08%

$NVS156.79+0.29%